Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raluca Munteanu

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Best Practice & Research. Clinical Haematology|September 7, 2025
Adoptive cellular therapies in multiple myelomaDavid Kegyes, Bogdan Borlea, Marc Damian, et al.
International Journal of Pharmaceutics|December 6, 2025
Targeting inflammation and oxidative stress in experimental colitis through IL-6 siRNA and ascorbic acid co-loaded trimethyl chitosan nanoparticlesDana Hales, Alina Porfire, Diana Cenariu, et al.
Best Practice & Research. Clinical Haematology|September 7, 2025
Adoptive cellular therapies in non-Hodgkin lymphomasDavid Kegyes, Bogdan Borlea, Marc Damian, et al.
Journal of Clinical Medicine|March 28, 2026
Mechanical Complications After Acute Myocardial Infarction: A Shock-Stage and Timing-Based Management FrameworkCaius Glad Streian, Ramona Cristina Novaconi, Iulia Raluca Munteanu, et al.
Biomarker Research|August 15, 2025
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myelomaDavid Kegyes, Anamaria Bancos, Adrian Bogdan Tigu, et al.
Journal of Cellular and Molecular Medicine|June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancySabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
International Journal of Molecular Sciences|June 19, 2024
Minimal Change Disease: Pathogenetic Insights from Glomerular ProteomicsAndrada Alina Bărar, Ioana-Ecaterina Pralea, Yuriy Maslyennikov, et al.
Frontiers in Immunology|August 27, 2025
Challenges in the preclinical design and assessment of CAR-T cellsRadu Tomai, Javier De Las Rivas, Bogdan Fetica, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Blood Reviews|November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseasesAdrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Best Practice & Research. Clinical Haematology|September 7, 2025
Adoptive cellular therapies in multiple myelomaDavid Kegyes, Bogdan Borlea, Marc Damian, et al.
International Journal of Pharmaceutics|December 6, 2025
Targeting inflammation and oxidative stress in experimental colitis through IL-6 siRNA and ascorbic acid co-loaded trimethyl chitosan nanoparticlesDana Hales, Alina Porfire, Diana Cenariu, et al.
Best Practice & Research. Clinical Haematology|September 7, 2025
Adoptive cellular therapies in non-Hodgkin lymphomasDavid Kegyes, Bogdan Borlea, Marc Damian, et al.
Journal of Clinical Medicine|March 28, 2026
Mechanical Complications After Acute Myocardial Infarction: A Shock-Stage and Timing-Based Management FrameworkCaius Glad Streian, Ramona Cristina Novaconi, Iulia Raluca Munteanu, et al.
Biomarker Research|August 15, 2025
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myelomaDavid Kegyes, Anamaria Bancos, Adrian Bogdan Tigu, et al.
Journal of Cellular and Molecular Medicine|June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancySabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
International Journal of Molecular Sciences|June 19, 2024
Minimal Change Disease: Pathogenetic Insights from Glomerular ProteomicsAndrada Alina Bărar, Ioana-Ecaterina Pralea, Yuriy Maslyennikov, et al.
Frontiers in Immunology|August 27, 2025
Challenges in the preclinical design and assessment of CAR-T cellsRadu Tomai, Javier De Las Rivas, Bogdan Fetica, et al.
Journal of Cellular and Molecular Medicine|September 28, 2024
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromesDiana Gulei, Vlad Moisoiu, David Kegyes, et al.
Blood Reviews|November 29, 2025
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseasesAdrian-Bogdan Tigu, Madalina Nistor, Diana Gulei, et al.
Pageof 4